SOL-GEL TECHNOLOGIES LTD (SLGL) Stock Fundamental Analysis

NASDAQ:SLGL • IL0011417206

91.68 USD
+2.53 (+2.84%)
Last: Feb 27, 2026, 08:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

Overall SLGL gets a fundamental rating of 4 out of 10. We evaluated SLGL against 193 industry peers in the Pharmaceuticals industry. While SLGL has a great health rating, there are worries on its profitability. SLGL is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • SLGL had negative earnings in the past year.
  • SLGL had a negative operating cash flow in the past year.
  • SLGL had negative earnings in 4 of the past 5 years.
  • SLGL had a negative operating cash flow in each of the past 5 years.
SLGL Yearly Net Income VS EBIT VS OCF VS FCFSLGL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M

1.2 Ratios

  • SLGL has a better Return On Assets (-8.68%) than 70.47% of its industry peers.
  • SLGL has a better Return On Equity (-10.70%) than 73.58% of its industry peers.
Industry RankSector Rank
ROA -8.68%
ROE -10.7%
ROIC N/A
ROA(3y)-40.55%
ROA(5y)-33.3%
ROE(3y)-47.5%
ROE(5y)-38.86%
ROIC(3y)N/A
ROIC(5y)N/A
SLGL Yearly ROA, ROE, ROICSLGL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150 -200

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for SLGL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SLGL Yearly Profit, Operating, Gross MarginsSLGL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K -20K -25K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • SLGL does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, SLGL has about the same amount of shares outstanding.
  • Compared to 5 years ago, SLGL has more shares outstanding
  • SLGL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SLGL Yearly Shares OutstandingSLGL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M
SLGL Yearly Total Debt VS Total AssetsSLGL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • An Altman-Z score of 13.71 indicates that SLGL is not in any danger for bankruptcy at the moment.
  • SLGL has a Altman-Z score of 13.71. This is amongst the best in the industry. SLGL outperforms 84.46% of its industry peers.
  • SLGL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 13.71
ROIC/WACCN/A
WACC8.58%
SLGL Yearly LT Debt VS Equity VS FCFSLGL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

2.3 Liquidity

  • SLGL has a Current Ratio of 7.32. This indicates that SLGL is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of SLGL (7.32) is better than 73.06% of its industry peers.
  • A Quick Ratio of 7.32 indicates that SLGL has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 7.32, SLGL is in the better half of the industry, outperforming 73.58% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 7.32
Quick Ratio 7.32
SLGL Yearly Current Assets VS Current LiabilitesSLGL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. Growth

3.1 Past

  • SLGL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -54.91%.
  • The Revenue has grown by 62.04% in the past year. This is a very strong growth!
  • SLGL shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 64.25% yearly.
EPS 1Y (TTM)-54.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2030%
Revenue 1Y (TTM)62.04%
Revenue growth 3Y-43.83%
Revenue growth 5Y64.25%
Sales Q2Q%-92.54%

3.2 Future

  • The Earnings Per Share is expected to grow by 15.10% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 94.55% on average over the next years. This is a very strong growth
EPS Next Y97.17%
EPS Next 2Y38.75%
EPS Next 3Y9.48%
EPS Next 5Y15.1%
Revenue Next Year870.39%
Revenue Next 2Y328.73%
Revenue Next 3Y56.77%
Revenue Next 5Y94.55%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SLGL Yearly Revenue VS EstimatesSLGL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20M 40M 60M 80M
SLGL Yearly EPS VS EstimatesSLGL Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -10 -20 -30

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for SLGL. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SLGL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SLGL Price Earnings VS Forward Price EarningsSLGL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SLGL Per share dataSLGL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.75%
EPS Next 3Y9.48%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for SLGL!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SOL-GEL TECHNOLOGIES LTD

NASDAQ:SLGL (2/27/2026, 8:00:02 PM)

91.68

+2.53 (+2.84%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-20
Earnings (Next)03-23
Inst Owners26.46%
Inst Owner Change0%
Ins Owners5.14%
Ins Owner ChangeN/A
Market Cap255.79M
Revenue(TTM)18.97M
Net Income(TTM)-3.41M
Analysts82.86
Price Target112.2 (22.38%)
Short Float %0.9%
Short Ratio0.33
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)233.88%
Min Revenue beat(2)-15.77%
Max Revenue beat(2)483.54%
Revenue beat(4)2
Avg Revenue beat(4)119.23%
Min Revenue beat(4)-86.37%
Max Revenue beat(4)483.54%
Revenue beat(8)4
Avg Revenue beat(8)101.43%
Revenue beat(12)5
Avg Revenue beat(12)51.51%
Revenue beat(16)7
Avg Revenue beat(16)32.65%
PT rev (1m)120%
PT rev (3m)120%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-85%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)227.17%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 10.69
P/FCF N/A
P/OCF N/A
P/B 8.02
P/tB 8.02
EV/EBITDA N/A
EPS(TTM)-10.1
EYN/A
EPS(NY)-0.75
Fwd EYN/A
FCF(TTM)-2.04
FCFYN/A
OCF(TTM)-2.03
OCFYN/A
SpS8.58
BVpS11.43
TBVpS11.43
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -8.68%
ROE -10.7%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-40.55%
ROA(5y)-33.3%
ROE(3y)-47.5%
ROE(5y)-38.86%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.32
Quick Ratio 7.32
Altman-Z 13.71
F-Score4
WACC8.58%
ROIC/WACCN/A
Cap/Depr(3y)23.47%
Cap/Depr(5y)26.73%
Cap/Sales(3y)4.34%
Cap/Sales(5y)3.72%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-54.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2030%
EPS Next Y97.17%
EPS Next 2Y38.75%
EPS Next 3Y9.48%
EPS Next 5Y15.1%
Revenue 1Y (TTM)62.04%
Revenue growth 3Y-43.83%
Revenue growth 5Y64.25%
Sales Q2Q%-92.54%
Revenue Next Year870.39%
Revenue Next 2Y328.73%
Revenue Next 3Y56.77%
Revenue Next 5Y94.55%
EBIT growth 1Y71.63%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y50.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y49.8%
OCF growth 3YN/A
OCF growth 5YN/A

SOL-GEL TECHNOLOGIES LTD / SLGL FAQ

Can you provide the ChartMill fundamental rating for SOL-GEL TECHNOLOGIES LTD?

ChartMill assigns a fundamental rating of 4 / 10 to SLGL.


What is the valuation status for SLGL stock?

ChartMill assigns a valuation rating of 0 / 10 to SOL-GEL TECHNOLOGIES LTD (SLGL). This can be considered as Overvalued.


Can you provide the profitability details for SOL-GEL TECHNOLOGIES LTD?

SOL-GEL TECHNOLOGIES LTD (SLGL) has a profitability rating of 1 / 10.


Can you provide the financial health for SLGL stock?

The financial health rating of SOL-GEL TECHNOLOGIES LTD (SLGL) is 8 / 10.